Ginkgo biloba for cognitive impairment and dementia (updated review)
Cochrane Dementia and Cognitive Improvement Group
Published in Cochrane Database of Systematic Reviews
Abstract
Updated review evaluating benefits and harms of Ginkgo biloba for cognitive impairment, dementia, or subjective cognitive complaints.
Methodology
Updated systematic search and meta-analysis of RCTs of Ginkgo biloba versus placebo.
Key Findings
It remains uncertain whether Ginkgo is better than placebo for improving overall cognitive condition at six months; certainty of evidence was low to very low.
Conclusions
Current evidence remains insufficient to determine whether Ginkgo biloba provides meaningful cognitive benefit.
Limitations
Low to very low certainty evidence; heterogeneity in populations, dosing, and follow-up duration.
Supplements Studied
It remains uncertain whether Ginkgo is better than placebo for improving overall cognitive condition at six months; certainty of evidence was low to very low.
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Cochrane Dementia and Cognitive Improvement Group
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.